PDF herunterladen
Thromb Haemost 1992; 68(03): 357-363
DOI: 10.1055/s-0038-1656380
Original Article
Schattauer GmbH Stuttgart

Low Molecular Weight Fibrinogen Degradation Products Stimulate the Release of Growth Factors from Endothelial Cells

Roberto Lorenzet
1   The Istituto di Ricerche Farmacologiche “Mario Negri”, Consorzio Mario Negri Sud, S. Maria Imbaro (CH), Italy
,
Joan H Sobel
2   The Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA
,
Alessandra Bini
1   The Istituto di Ricerche Farmacologiche “Mario Negri”, Consorzio Mario Negri Sud, S. Maria Imbaro (CH), Italy
3   The Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, NY, USA
,
Larry D Witte
2   The Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 23. Dezember 1991

Accepted after revision 25. März 1992

Publikationsdatum:
04. Juli 2018 (online)

Auch verfügbar auf
  als PDF herunterladen  Lizenzen und Reprints

Summary

Cultured porcine aortic endothelial cells (PAEC) constitutively produce and secrete in their culture medium mitogens collectively called endothelial cell-derived growth factors (EDGFs). Incubation of PAEC with fibrinogen-degradation products (FDPs) obtained by plasmin digestion of highly purified fibrinogen caused an increased release of EDGFs, as assessed by [3H]-thymidine incorporation in 3T3 mouse fibroblasts. The effect was time-dependent and correlated with the degree of fibrinogenolysis. It was accompanied by elongation of the cells. Neither increase in EDGFs release nor cell damage was observed when non-degraded fibrinogen was incubated with endothelial cells. Low molecular weight fibrinogen degradation products (LMWFDPs) (M r ≤ 10,000), and the higher molecular weight fibrinogen fragments D and E were tested under the same conditions. Only the LMWFDPs caused elongation and damage to PAEC and a marked stimulation (up to 12 fold) of EDGFs release. A low density growth assay revealed that the released EDGFs were mitogenically active on the same PAEC. The activity of the released EDGFs was time and dose dependent on both 3T3 fibroblasts and PAEC, indicating that LMWFDPs caused enhanced release of EDGFs that can act in paracrine and autocrine fashion. This study suggests an additional role for fibrinogenolysis contributing to wound healing, and possibly to atherosclerosis.

 

  • References

  • 1 Gajdusek C, DiCorleto P, Ross R, Schwartz SM. An endothelial cell-derived growth factor. J Cell Biol 1980; 85: 467-472
    CrossrefPubMedGoogle Scholar
  • 2 Cornicelli JA, Witte LD, Goodman DS. Inhibition of LDL degradation in cultured human fibroblasts induced by endothelial cell-conditioned medium. Arteriosclerosis 1983; 3: 560-567
    CrossrefPubMedGoogle Scholar
  • 3 DiCorleto PE, Bowen-Pope DF. Cultured endothelial cells produce a platelet derived growth factor-like protein. USA: Proc Natl Acad Sci 1983; 80: 1919-1923
    PubMedGoogle Scholar
  • 4 Witte LD, Cornicelli JA, Miller RW, Goodman DS. Effects of platelet-derived and endothelial cell-derived growth factors on the low density lipoprotein receptor pathway in cultured human fibroblasts. J Biol Chem 1982; 257: 5392-5401
    PubMedGoogle Scholar
  • 5 Schweigerer L, Neufeld G, Friedman J, Abraham JA, Fiddes JC, Gospodarowicz D. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 1987; 325: 257-259
    CrossrefPubMedGoogle Scholar
  • 6 Sato Y, Rifkin DB. Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol 1988; 107: 1199-1205
    CrossrefPubMedGoogle Scholar
  • 7 Fox PL, DiCorleto PE. Regulation of production of a platelet-derived growth factor-like protein by cultured bovine aortic endothelial cells. J Cell Physiol 1984; 121: 298-308
    CrossrefPubMedGoogle Scholar
  • 8 Hajjar KA, Hajjar DP, Silverstein RL, Nachman RL. Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells. J Exp Med 1987; 166: 235-245
    CrossrefPubMedGoogle Scholar
  • 9 Gajdusek C, Carbon S, Ross R, Nawroth P, Stern D. Activation of coagulation releases endothelial cell mitogens. J Cell Biol 1986; 103: 419-428
    CrossrefPubMedGoogle Scholar
  • 10 Harlan JM, Thompson PJ, Ross RR, Bowen-Pope DF. α-Thrombin induces release of platelet-derived growth factor-like molecule(s) by cultured human endothelial cells. J Cell Biol 1986; 103: 1129-1133
    CrossrefPubMedGoogle Scholar
  • 11 Doolittle RF. Fibrinogen and fibrin. Ann Rev Biochem 1984; 53: 195-229
    CrossrefPubMedGoogle Scholar
  • 12 Kadish JL, Butterfield CE, Folkman J. The effect of fibrin on cultured vascular endothelial cells. Tissue Cell 1979; 11: 099-108
    CrossrefPubMedGoogle Scholar
  • 13 Rowland FN, Donovan MJ, Picciano PT, Wilner GD, Kreutzer DL. Fibrin-mediated vascular injury. Identification of fibrin peptides that mediate endothelial cell retraction. Am J Pathol 1984; 117: 418-428
    PubMedGoogle Scholar
  • 14 Andersson RGG, Saldeen K, Saldeen T. A fibrin(ogen) derived pentapeptide induces vasodilation, prostacyclin release and an increase in cyclic AMP. Thromb Res 1983; 30: 213-218
    CrossrefPubMedGoogle Scholar
  • 15 Richardson DL, Pepper DS, Kay AB. Chemotaxis for human monocytes by fibrinogen-derived peptides. Br J Haematol 1976; 32: 507-513
    CrossrefPubMedGoogle Scholar
  • 16 Saldeen K, Christie N, Nelson WR, Movat HZ. Effect of a fibrin (ogen)-derived vasoactive peptide on polymorphonuclear leukocyte emigration. Thromb Res 1985; 37: 85-89
    CrossrefPubMedGoogle Scholar
  • 17 Thompson WD, Campbell R, Evans T. Fibrin degradation and angiogenesis: quantitative analysis of the angiogenic response in the chick chorioallantoic membrane. J Pathol 1985; 145: 27-37
    CrossrefPubMedGoogle Scholar
  • 18 Smith EB, Staples EM, Dietz HS, Smith RH. Role of endothelium in sequestration of lipoprotein and fibrinogen in aortic lesions, thrombi, and graft pseudo-intimas. Lancet 1979; ii: 812-816
    PubMedGoogle Scholar
  • 19 Bini A, Fenoglio Jr JJ, Mesa-Tejada R, Kudryk B, Kaplan K. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Arteriosclerosis 1989; 9: 109-121
    PubMedGoogle Scholar
  • 20 Witte L, Fuks Z, Haimovitz-Friedman A, Vlodavsky I, Goodman DS, Eldor A. Effects of irradiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells. Cancer Res 1989; 49: 5066-5072
    PubMedGoogle Scholar
  • 21 Koehn JA, Canfield RE. Purification of human fibrinopeptides by high performance liquid chromatography. Anal Biochem 1981; 116: 349-356
    CrossrefPubMedGoogle Scholar
  • 22 Dreyfuss G, Adam SA, Choi YD. Physical change in cytoplasmic messenger ribonucleoproteins in cells treated with inhibitors of mRNA transcription. Mol Cell Biol 1984; 4: 415-423
    CrossrefPubMedGoogle Scholar
  • 23 Sobel JH, Thibodeau CA, Gawinowicz MA, Canfield RE. Immunochemical characterization of crosslinked derivatives isolated from alpha chain oligomers formed during early stages of fibrin crosslinking. Thromb Haemostas 1988; 60: 160-169
    PubMedGoogle Scholar
  • 24 Rupp C, Sievi R, Furlan M. Fractionation of plasmic fibrinogen digest on lysine-agarose. Isolation of two fragments D, fragment E and simultaneous removal of plasmin. Thromb Res 1982; 27: 117-121
    PubMedGoogle Scholar
  • 25 Moscatelli D. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in stimulation of plasminogen activator production by bovine capillary endothelial cells. J Cell Physiol 1987; 131: 123-130
    CrossrefPubMedGoogle Scholar
  • 26 Gospodarowicz D, Moran J, Braun D, Birdwell C. Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent. USA: Proc Natl Acad Sci 1976; 73: 4120-4124
    PubMedGoogle Scholar
  • 27 Bowen-Pope DF, Ross R. Platelet-derived growth factor. II. Specific binding to cultured cells. J Biol Chem 1982; 257: 5161-5171
    PubMedGoogle Scholar
  • 28 Ross R. The pathogenesis of atherosclerosis – An update. N Engl J Med 1986; 314: 488-500
    CrossrefPubMedGoogle Scholar
  • 29 Rokitansky C. A manual of pathological anatomy. London: The Sydenham Society: 1852. pp 261-273
    Google Scholar
  • 30 Kaplan KL, Bini A. Thrombosis in atherogenesis. Crit Rev Oncol/Hematol 1989; 9: 305-318
    CrossrefPubMedGoogle Scholar
  • 31 Smith EB, Keen GA, Grant A, Stirk C. Fate of fibrinogen in human arterial intima. Arteriosclerosis 1990; 10: 263-275
    CrossrefPubMedGoogle Scholar
  • 32 Sadoshima S, Tanaka K. Fibrinogen and low density lipoprotein in the development of cerebral atherosclerosis. Atherosclerosis 1979; 34: 093-103
    CrossrefPubMedGoogle Scholar
  • 33 Bini A, Fenoglio Jr J, Sobel J, Owen J, Fejgl M, Kaplan KL. Immunochemical characterization of fibrinogen, Fibrin I, and Fibrin II in human thrombi and atherosclerotic lesions. Blood 1987; 69: 1038-1045
    PubMedGoogle Scholar
  • 34 Watanabe K, Tanaka K. Influence of fibrin, fibrinogen and fibrinogen degradation products on cultured endothelial cells. Atherosclerosis 1983; 48: 57-70
    CrossrefPubMedGoogle Scholar
  • 35 Barrett TB, Benditt EP. sis (platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery. USA: Proc Natl Acad Sci 1987; 84: 1099-1103
    PubMedGoogle Scholar
  • 36 Wilcox JN, Smith KM, Williams LT, Schwartz SM, Gordon D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest 1988; 82: 1134-1143
    CrossrefPubMedGoogle Scholar
  • 37 Barrett TB, Gajdusek CM, Schwartz SM, McDougall JK, Benditt EP. Expression of the sis gene by endothelial cells in culture in vivo. USA: Proc Natl Acad Sci 1984; 81: 6772-6774
    PubMedGoogle Scholar
  • 38 Collins T, Ginsburg D, Boss JM, Orkin SH, Pober JS. Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis. Nature (Lond) 1985; 316: 748-750
    CrossrefPubMedGoogle Scholar
  • 39 Collins T, Pober JS, Gimbrone MA, Hammacher A, Betsholtz C, Westemark B, Heldin CH. Cultured human endothelial cells express platelet-derived growth factor A chain. Am J Pathol 1987; 126: 07-12
    PubMedGoogle Scholar
  • 40 Starksen NF, Harsh GR, Gibbs VC, Williams LT. Regulated expression of the platelet derived growth factor A chain gene in microvascular endothelial cells. J Biol Chem 1987; 262: 14381-14384
    PubMedGoogle Scholar
  • 41 Gospodarowicz D, Neufeld G, Schweigerer L. Fibroblast growth factor. Mol Cell Endocrinol 1986; 46: 187-204
    CrossrefPubMedGoogle Scholar
  • 42 Vlodavsky I, Fridman R, Sullivan R, Sasse JJ, Klagsbrun M. Aortic endothelial cells synthesize, basic fibroblast growth factor which remains cell associated and platelet-derived growth factor-like protein which is secreted. J Cell Physiol 1987; 131: 402-408
    CrossrefPubMedGoogle Scholar
  • 43 Dejana E, Vergara-Dauden M, Balconi G, Pietra A, Cherel G, Donati MB, Larrieu MJ, Marguerie G. Specific binding of human fibrinogen to cultured human fibroblasts. Evidence for the involvement of the E domain. Eur J Biochem 1984; 139: 657-662
    PubMedGoogle Scholar
  • 44 Dejana E, Languino LR, Polentarutti N, Balconi G, Ryckewaert JJ, Larrieu MJ, Donati MB, Mantovani A, Marguerie G. Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. J Clin Invest 1985; 75: 11-18
    PubMedGoogle Scholar
  • 45 Wang Y, Fuller GM. The putative role of fibrin fragments in the biosynthesis of fibrinogen by hepatoma cells. Biochem Biophys Res Comm 1991; 175: 562-567
    CrossrefPubMedGoogle Scholar
  • 46 Hatzfeld JA, Hatzfeld A, Maigne J. Fibrinogen and its fragment D stimulate proliferation of human hemopoietic cells in vitro. USA: Proc Natl Acad Sci 1982; 79: 6280-6284
    PubMedGoogle Scholar
  • 47 Ishida T, Tanaka K. Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture. Atherosclerosis 1982; 44: 161-174
    CrossrefPubMedGoogle Scholar
  • 48 Delvos U, Muller-Berghaus G. Influence of the fibrin(ogen) degradation product fragment D on the monolayer integrity of cultured vascular endothelial cells. Failure to induce monolayer disorganization. Haemostasis 1988; 18: 099-105
    PubMedGoogle Scholar
  • 49 Busch C, Gerdin B. Effect of low molecular weight fibrin degradation products on endothelial cells in culture. Thromb Res 1981; 22: 33-39
    CrossrefPubMedGoogle Scholar
  • 50 Gerdin B, Saldeen T. Effect of fibrin degradation products on microvascular permeability. Thromb Res 1978; 13: 0995-1006
    CrossrefPubMedGoogle Scholar
  • 51 McNeil PL, Muthukrishnan L, Warder E, D’Amore PA. Growth factors are released by mechanically wounded cells. J Cell Biol 1989; 109: 811-822
    CrossrefPubMedGoogle Scholar
  • 52 Neufeld G, Gospodarowicz D. Identification of the fibroblast growth factor receptor in human vascular endothelial cells. J Cell Physiol 1988; 136: 537-542
    CrossrefPubMedGoogle Scholar